Thursday, July 9, 2026

pharma · Parkinson's Disease · PARKINSON DISEASE (Disorder) · SER

Serina Therapeutics

Serina Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Huntsville, USA HQ
2007 Founded
23 Employees
Public company Type
SER · NYSE Ticker
Company details
Status
Public
HQ
Huntsville, USA
Founded
2007
Employees
23
Programs
2
Drugs
3
Patents
25
Intelligence · Clinical Trials

Serina Therapeutics clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Serina Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Serina Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Serina Therapeutics.

  1. SER-252 (PEOZ-apomorphine) — Phase 1

    Clinical update
  2. SER-214 — Phase 1

    Clinical update
  3. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant
  4. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant
  5. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant
  6. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant
  7. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant
  8. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Patent grant

Trial registry

2 studies